- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of precision medicine: a scoping review
Authors
Keywords
-
Journal
International Journal of Public Health
Volume 64, Issue 9, Pages 1261-1271
Publisher
Springer Science and Business Media LLC
Online
2019-10-26
DOI
10.1007/s00038-019-01298-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance
- (2018) Courtney J. Balentine et al. SURGERY
- Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation
- (2017) Tristan Snowsill et al. HEALTH TECHNOLOGY ASSESSMENT
- Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia
- (2017) Pablo Lázaro et al. Journal of Clinical Lipidology
- Incremental cost-effectiveness of algorithm-driven genetic testing versus no testing for Maturity Onset Diabetes of the Young (MODY) in Singapore
- (2017) Hai Van Nguyen et al. JOURNAL OF MEDICAL GENETICS
- Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions
- (2017) Ching-Hua Ke et al. JOURNAL OF RHEUMATOLOGY
- A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives
- (2017) Zanfina Ademi et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype
- (2017) Laura Hörster et al. LEUKEMIA RESEARCH
- Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
- (2017) James Buchanan et al. PHARMACOECONOMICS
- Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
- (2017) M Verbelen et al. PHARMACOGENOMICS JOURNAL
- Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome
- (2017) Y Wang et al. PHARMACOGENOMICS JOURNAL
- A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events
- (2017) M E Moretti et al. PHARMACOGENOMICS JOURNAL
- A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer
- (2017) Yonghong Li et al. VALUE IN HEALTH
- Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis
- (2017) Louis P. Garrison et al. VALUE IN HEALTH
- Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany
- (2016) Marika Plöthner et al. ADVANCES IN THERAPY
- Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations
- (2016) Elvira D’Andrea et al. GENETICS IN MEDICINE
- Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age
- (2016) Anne Goverde et al. GYNECOLOGIC ONCOLOGY
- A personalized paradigm in the treatment of platinum-resistant ovarian cancer – A cost utility analysis of genomic-based versus cytotoxic therapy
- (2016) J.J. Wallbillich et al. GYNECOLOGIC ONCOLOGY
- A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions
- (2016) Catrin O. Plumpton et al. PHARMACOECONOMICS
- HLA-B*57
- (2016) Cristina Ruiz-Iruela et al. Pharmacogenetics and Genomics
- Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden
- (2016) T I Verhoef et al. PHARMACOGENOMICS JOURNAL
- Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea
- (2016) Eun-A Lim et al. PLoS One
- Other side of the coin for personalised medicine and healthcare: content analysis of ‘personalised’ practices in the literature
- (2016) Tomris Cesuroglu et al. BMJ Open
- Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature
- (2016) Elizabeth J. J. Berm et al. PLoS One
- Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan
- (2016) Ying-Erh Chen et al. PLoS One
- A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients
- (2015) Tristan Snowsill et al. BMC CANCER
- Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis
- (2015) Dov Shiffman et al. BMC Cardiovascular Disorders
- Cost-effectiveness of screening forHLA-A*31:01prior to initiation of carbamazepine in epilepsy
- (2015) Catrin O. Plumpton et al. EPILEPSIA
- Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis
- (2015) Carlos J. Gallego et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Effectiveness of Screening Strategies for Lynch Syndrome
- (2015) Afsaneh Barzi et al. JNCI-Journal of the National Cancer Institute
- Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer
- (2015) Yusuke Narita et al. LUNG CANCER
- Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany
- (2015) Katharina Schremser et al. PHARMACOECONOMICS
- Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice
- (2015) Bruce R Schackman et al. PHARMACOGENOMICS
- Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis
- (2015) Joyce HS You PHARMACOGENOMICS
- Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions
- (2015) O Alagoz et al. PHARMACOGENOMICS JOURNAL
- A Systematic Review on the Cost-Effectiveness of Genetic and Electrocardiogram Testing for Long QT Syndrome in Infants and Young Adults
- (2015) Fernando Matias Gonzalez et al. VALUE IN HEALTH
- Comparative Effectiveness of Screening Strategies for Lynch Syndrome
- (2015) Afsaneh Barzi et al. JNCI-Journal of the National Cancer Institute
- Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria
- (2015) B. Jahn et al. SpringerPlus
- Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine
- (2015) Ildar Akhmetov et al. EPMA Journal
- Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism
- (2015) C. Rubio-Terrés et al. Applied Health Economics and Health Policy
- Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan
- (2014) Hideko Yamauchi et al. BMC HEALTH SERVICES RESEARCH
- A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
- (2014) Tristan Snowsill et al. HEALTH TECHNOLOGY ASSESSMENT
- HEALTH TECHNOLOGY ASSESSMENT AND PERSONALIZED MEDICINE: ARE ECONOMIC EVALUATION GUIDELINES SUFFICIENT TO SUPPORT DECISION MAKING?
- (2014) Don Husereau et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia
- (2014) Zanfina Ademi et al. Journal of Clinical Lipidology
- Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
- (2014) Ranjit Manchanda et al. JNCI-Journal of the National Cancer Institute
- Is Individualized Medicine More Cost-Effective? A Systematic Review
- (2014) Maximilian H. M. Hatz et al. PHARMACOECONOMICS
- Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
- (2014) Surasak Saokaew et al. PLoS One
- BRAF mutation in papillary thyroid cancer: A cost-utility analysis of preoperative testing
- (2014) Wayne S. Lee et al. SURGERY
- Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand
- (2014) Huey Yi Chong et al. THROMBOSIS RESEARCH
- Economic Evaluation of Using a Genetic Test to Direct Breast Cancer Chemoprevention in White Women with a Previous Breast Biopsy
- (2014) Linda E. Green et al. Applied Health Economics and Health Policy
- Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation
- (2013) J Pink et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
- (2013) Rochelle N. Naylor et al. DIABETES CARE
- The economic value of personalized medicine tests: what we know and what we need to know
- (2013) Kathryn A Phillips et al. GENETICS IN MEDICINE
- Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation
- (2013) Joyce H.S. You Pharmacogenetics and Genomics
- Herausforderungen an die klinische Evaluation und Gesundheitsökonomie auf dem Weg zur personalisierten Medizin
- (2012) B. Brüggenjürgen et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
- (2012) Eric Faulkner et al. VALUE IN HEALTH
- How Affordable are Targeted Therapies in Non-Small Cell Lung Cancer?
- (2011) Linda E. Coate et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature
- (2010) Stefan Vegter et al. DRUG DEVELOPMENT RESEARCH
- Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities
- (2010) Rena Conti et al. MEDICAL DECISION MAKING
- Cost Effectiveness of Pharmacogenomics
- (2010) William B. Wong et al. PHARMACOECONOMICS
- Systematic review of pharmacoeconomic studies of pharmacogenomic tests
- (2010) Mathieu Beaulieu et al. PHARMACOGENOMICS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Pharmacoeconomics in the Era of Individualized Medicine
- (2008) SA Waldman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis
- (2008) Scott D Grosse et al. GENETICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More